News
In the case, Maryland woman Keosha Diggs alleged that her son developed a life-threatening intestinal disease called ...
In its campaign against “woke” science, the N.I.H. has closed down studies and programs focused on the gaps between racial ...
US National Institutes of Health Director Dr. Jay Bhattacharya on Friday released a statement outlining a “unified strategy” ...
Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research ...
The U.S. Department of Health and Human Services said on Thursday it is reinstating a federal task force for safer childhood ...
The auditorium at the Black Maternal and Infant Health Conference was silent as Thomas shared the story of her cousin, ...
Trethera Corporation ('Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...
NIH director Jay Bhattacharya said that among other priorities, the agency will focus on artificial intelligence and ...
Five months since the Trump administration rolled out grand plans for a signature health agency, Congress has shied away from ...
The number of people receiving treatment at the National Institutes of Health Clinical Center—the renowned research hospital ...
NIH Director Jay Bhattacharya said the agency is prioritizing AI and real-world data platforms to advance a unified strategy.
Monument Therapeutics, a stratified medicine company, today announced a partnership with the Foundation for the National Institutes of Health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results